N-(1-(4-methoxybenzyl)piperidin-4-yl)-6-(4-(4-(methylsulfonyl)phenoxy)piperidine-1-carbonyl)nicotinamide | 1356627-29-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(1-(4-methoxybenzyl)piperidin-4-yl)-6-(4-(4-(methylsulfonyl)phenoxy)piperidine-1-carbonyl)nicotinamide
• 英文别名: N-(1-(4-methoxybenzyl) piperidin-4-yl)-6-(4-(4-(methylsulfonyl) phenoxy)piperidine-1-carbonyl)nicotinamide；N-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide
• CAS: 1356627-29-6
• 化学式: C₃₂H₃₈N₄O₆S
• 分子量: 606.743
• InChiKey: DCJUOYBOVODPDJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  43
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  127
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
  申请人：Goff Dane

  公开号：US20120028954A1

  公开（公告）日：2012-02-02

  Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R 3 , R 4 , w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

  本发明涉及取代吡啶化合物以及其药物组合物和使用方法。其中一种实施例是一种具有以下结构的化合物，其中E、J、T、用“B”表示的环系统、T、R3、R4、w和x如本文所述。在某些实施例中，本文所披露的化合物可以激活AMPK途径，并可用于治疗与新陈代谢有关的疾病和症状。
• METHODS FOR USING AND BIOMARKERS FOR AMPK-ACTIVATING COMPOUNDS
  申请人：Hitoshi Yasumichi

  公开号：US20150087673A1

  公开（公告）日：2015-03-26

  Disclosed are methods of using AMPK-activating compounds, for example, in the treatment of cancer and disorders of vascular flow. Also disclosed are biomarkers for AMPK and uses thereof, for example, in the diagnosis and treatment of AMPK-linked disorders. In certain embodiments, the AMPK-activating compounds have the structural formula wherein E, J, T, D 1 , D 2 , D 3 , the ring system denoted by “B”, T, R 3 , R 4 , w and x are as described herein.

  本文公开了使用AMPK激活化合物的方法，例如在癌症和血管流动障碍的治疗中的应用。还公开了AMPK的生物标志物及其用途，例如在AMPK相关疾病的诊断和治疗中的应用。在某些实施例中，AMPK激活化合物具有以下结构式，其中E、J、T、D1、D2、D3、由“B”表示的环系统、T、R3、R4、w和x如本文所述。
• AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME
  申请人：RIGEL PHARMACEUTICALS, INC.

  公开号：US20130267701A1

  公开（公告）日：2013-10-10

  Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R 3 , R 4 , w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

  本发明涉及取代吡啶化合物、药物组合物和使用方法。其中一种实施方式是具有以下结构的化合物，其中E、J、T、由“B”表示的环系统、T、R3、R4、w和x如所述。在某些实施方式中，本文所披露的化合物可以激活AMPK通路，并可用于治疗与代谢有关的疾病和病症。
• AMPK-activating heterocyclic compounds and methods for using the same
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US10377742B2

  公开（公告）日：2019-08-13

  Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

  所公开的是取代的吡啶化合物以及药物组合物和使用方法。其中一种化合物具有如下结构 其中 E、J、T、以 "B "表示的环系、T、R3、R4、w 和 x 如本文所述。在某些实施方案中，本文公开的化合物可激活 AMPK 通路，并可用于治疗与代谢相关的疾病和病症。
• US8791136B2
  申请人：——

  公开号：US8791136B2

  公开（公告）日：2014-07-29